Cargando…

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents

[Image: see text] The continuing prevalence of drug-resistant tuberculosis threatens global TB control programs, highlighting the need to discover new drug candidates to feed the drug development pipeline. In this study, we describe a high-throughput screening hit (4-benzylpiperidin-1-yl)(1-(5-pheny...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Veena D., Boshoff, Helena I., Trifonov, Lena, Roma, Jose Santinni O., Ioerger, Thomas R., Barry, Clifton E., Oh, Sangmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510505/ https://www.ncbi.nlm.nih.gov/pubmed/37736177 http://dx.doi.org/10.1021/acsmedchemlett.3c00295

Ejemplares similares

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents
por: Oh, Sangmi, et al.
Publicado: (2021)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
por: Oh, Sangmi, et al.
Publicado: (2021)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
por: Mali, Suraj N., et al.
Publicado: (2022)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
por: Ramey, Michelle E., et al.
Publicado: (2023)

Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase
por: Oh, Sangmi, et al.
Publicado: (2018)

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents
por: Zampieri, Daniele, et al.
Publicado: (2022)

Conventional and Microwave-Assisted Synthesis, Antitubercular Activity, and Molecular Docking Studies of Pyrazole and Oxadiazole Hybrids
por: Desai, Nisheeth C., et al.
Publicado: (2021)

Exploration of Piperidinols as Potential Antitubercular Agents
por: Abuhammad, Areej, et al.
Publicado: (2014)

DER NEWSLETTER DES DPR
Publicado: (2022)

Synthesis and structure−activity relationship of 8-substituted protoberberine derivatives as a novel class of antitubercular agents
por: Li, Ying-Hong, et al.
Publicado: (2013)

Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
por: Makowska-Grzyska, Magdalena, et al.
Publicado: (2015)

DIP/Dpr interactions and the evolutionary design of specificity in protein families
por: Sergeeva, Alina P., et al.
Publicado: (2020)

Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies
por: Soares de Melo, Candice, et al.
Publicado: (2021)

Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis
por: Libardo, M. Daben J., et al.
Publicado: (2021)

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents
por: Peraman, Ramalingam, et al.
Publicado: (2016)

Resolution enhancement with deblurring by pixel reassignment (DPR)
por: Zhao, Bingying, et al.
Publicado: (2023)

Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents
por: Singh, Richa, et al.
Publicado: (2016)

Design, Synthesis, Toxicity Estimation and Molecular Docking Studies of N-(furan-2-yl)-1-(5-substituted) phenyl-1,3,4-oxadiazol-2-yl) methanimine as Antitubercular Agents
por: Mathew, B., et al.
Publicado: (2014)

The virulence of Streptococcus pneumoniae partially depends on dprA
por: Yu, Yi, et al.
Publicado: (2016)

New Quinoline–Urea–Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling
por: Moodley, Rashmika, et al.
Publicado: (2022)

Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents
por: Kar, Sidhartha S, et al.
Publicado: (2016)

Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents
por: Jesumoroti, Omobolanle Janet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0b326tnl5eett7dtqi1dcn6fqm